株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

電子ドラッグデリバリーシステム (DDS) の世界市場 - 2024年までの予測:電子ウェアラブル輸液ポンプ・電子自動注入器・電子注入ペン・電子吸入具

Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 914243
出版日 ページ情報 英文 125 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
電子ドラッグデリバリーシステム (DDS) の世界市場 - 2024年までの予測:電子ウェアラブル輸液ポンプ・電子自動注入器・電子注入ペン・電子吸入具 Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
出版日: 2019年10月15日 ページ情報: 英文 125 Pages
概要

世界の電子ドラッグデリバリーシステム (DDS) 市場は、2019年の78億米ドルから2024年までに119億米ドルへ達すると予測され、予測期間中は8.7%のCAGR (年間複合成長率) が見込まれています。同市場は主に北米 & 欧州における好ましい医療費償還シナリオ、糖尿病 & 心血管疾患といった標的疾患の有病率の増加、および技術・電子ドラッグデリバリーシステム (DDS) の設計における進歩などによって促進されています。また、中国やインドなどの新興市場は、今後数年のうちに市場参入企業へ潜在的な成長機会をもたらすと見込まれています。

当レポートでは、世界の電子ドラッグデリバリーシステム (DDS) 市場について調査分析し、市場概要、産業動向、各セグメント別・地域別による市場の分析と予測、競合情勢、主要企業などについて、体系的な情報を提供しています。

914243_4.1 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET OVERVIEW_FIGURE 9

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 電子ドラッグデリバリーシステム市場の概要
  • 北米の電子ドラッグデリバリーシステム市場:タイプ別
  • 電子ドラッグデリバリーシステム市場の地域スナップショット

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 電子ドラッグデリバリーシステム市場:タイプ別

  • イントロダクション
    • 電子ウェアラブル輸液ポンプ
    • 電子自動注入器
    • 電子注入ペン
    • 電子吸入具

第7章 電子ドラッグデリバリーシステム市場:適応症別

  • イントロダクション
  • 糖尿病
  • 多発性硬化症
  • 心血管疾患
  • 喘息 & COPD
  • その他の適応症

第8章 電子ドラッグデリバリーシステム市場:地域別

  • イントロダクション
  • 北米
  • アジア太平洋
  • その他 (RoW)

第9章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業の分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第10章 企業プロファイル

  • MERCK GROUP
  • MEDTRONIC PLC
  • UNITED THERAPEUTICS CORPORATION
  • INSULET CORPORATION
  • BAYER AG
  • NOVO NORDISK
  • COMPANION MEDICAL
  • TANDEM DIABETES CARE, INC.
  • F.HOFFMANN-LA ROCHE, LTD.
  • AMGEN, INC.
  • ASTRAZENECA PLC
  • FINDAIR SP. Z O. O.
  • VICENTRA B.V.
  • CANE SPA
  • DEBIOTECH S.A.

第11章 付録

図表

LIST OF TABLES

  • TABLE 1 COMMERCIALLY AVAILABLE BIOLOGICS AS POTENTIAL APPLICATIONS FOR ELECTRONIC DRUG DELIVERY SYSTEMS IN THE COMING YEARS 34
  • TABLE 2 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 37
  • TABLE 3 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 38
  • TABLE 4 COMPARATIVE TABLE OF COMMERCIALLY AVAILABLE INSULIN PUMPS 39
  • TABLE 5 ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY REGION, 2017-2024 (USD MILLION) 41
  • TABLE 6 NORTH AMERICA: ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 41
  • TABLE 7 EUROPE: ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 41
  • TABLE 8 ASIA PACIFIC: ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 42
  • TABLE 9 ROW: ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY REGION, 2017-2024 (USD MILLION) 42
  • TABLE 10 ELECTRONIC AUTOINJECTORS MARKET, BY REGION, 2017-2024 (USD MILLION) 43
  • TABLE 11 NORTH AMERICA: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 43
  • TABLE 12 EUROPE: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 43
  • TABLE 13 ASIA PACIFIC: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 44
  • TABLE 14 ROW: ELECTRONIC AUTOINJECTORS MARKET, BY REGION, 2017-2024 (USD MILLION) 44
  • TABLE 15 ELECTRONIC INJECTION PENS MARKET, BY REGION, 2017-2024 (USD MILLION) 45
  • TABLE 16 NORTH AMERICA: ELECTRONIC INJECTION PENS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 45
  • TABLE 17 EUROPE: ELECTRONIC INJECTION PENS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 45
  • TABLE 18 ASIA PACIFIC: ELECTRONIC INJECTION PENS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 46
  • TABLE 19 ROW: ELECTRONIC INJECTION PENS MARKET, BY REGION, 2017-2024 (USD MILLION) 46
  • TABLE 20 ELECTRONIC INHALERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 47
  • TABLE 21 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 49
  • TABLE 22 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20-79 YEARS), 2017 VS. 2045 50
  • TABLE 23 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY REGION, 2017-2024 (USD MILLION) 51
  • TABLE 24 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY COUNTRY, 2017-2024 (USD MILLION) 51
  • TABLE 25 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY COUNTRY, 2017-2024 (USD MILLION) 51
  • TABLE 26 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY COUNTRY, 2017-2024 (USD MILLION) 52
  • TABLE 27 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY REGION, 2017-2024 (USD MILLION) 52
  • TABLE 28 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2017-2024 (USD MILLION) 53
  • TABLE 29 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017-2024 (USD MILLION) 53
  • TABLE 30 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017-2024 (USD MILLION) 53
  • TABLE 31 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017-2024 (USD MILLION) 54
  • TABLE 32 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2017-2024 (USD MILLION) 54
  • TABLE 33 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2017-2024 (USD MILLION) 55
  • TABLE 34 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017-2024 (USD MILLION) 55
  • TABLE 35 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017-2024 (USD MILLION) 56
  • TABLE 36 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017-2024 (USD MILLION) 56
  • TABLE 37 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2017-2024 (USD MILLION) 56
  • TABLE 38 PREVALENCE OF COPD & ASTHMA IN 2010 AND 2016 (MILLION) 57
  • TABLE 39 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR ASTHMA & COPD, BY COUNTRY, 2017-2024 (USD MILLION) 58
  • TABLE 40 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY REGION, 2017-2024 (USD MILLION) 59
  • TABLE 41 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017-2024 (USD MILLION) 59
  • TABLE 42 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017-2024 (USD MILLION) 59
  • TABLE 43 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017-2024 (USD MILLION) 60
  • TABLE 44 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY REGION, 2017-2024 (USD MILLION) 60
  • TABLE 45 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION) 63
  • TABLE 46 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 63
  • TABLE 47 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 65
  • TABLE 48 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 66
  • TABLE 49 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 66
  • TABLE 50 US: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 67
  • TABLE 51 US: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 67
  • TABLE 52 CANADA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 68
  • TABLE 53 CANADA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 68
  • TABLE 54 EUROPE: RECENT DEVELOPMENTS IN THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, 2017-2018 69
  • TABLE 55 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 71
  • TABLE 56 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 71
  • TABLE 57 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 71
  • TABLE 58 GERMANY: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 72
  • TABLE 59 GERMANY: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 72
  • TABLE 60 UK: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 73
  • TABLE 61 UK: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 74
  • TABLE 62 FRANCE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 74
  • TABLE 63 FRANCE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 75
  • TABLE 64 ROE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 76
  • TABLE 65 ROE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 76
  • TABLE 66 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 78
  • TABLE 67 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 78
  • TABLE 68 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 78
  • TABLE 69 JAPAN: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 79
  • TABLE 70 JAPAN: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 80
  • TABLE 71 CHINA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 80
  • TABLE 72 CHINA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 81
  • TABLE 73 INDIA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 81
  • TABLE 74 INDIA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 82
  • TABLE 75 ROAPAC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 83
  • TABLE 76 ROAPAC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 83
  • TABLE 77 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION) 84
  • TABLE 78 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 85
  • TABLE 79 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 85
  • TABLE 80 LATIN AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 86
  • TABLE 81 LATIN AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 86
  • TABLE 82 MIDDLE EAST & AFRICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 87
  • TABLE 83 MIDDLE EAST & AFRICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION) 87
  • TABLE 84 PRODUCT LAUNCHES 89
  • TABLE 85 EXPANSIONS 89
  • TABLE 86 AGREEMENTS & COLLABORATIONS 90
  • TABLE 87 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD) 102

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN 18
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
  • FIGURE 3 BOTTOM-UP APPROACH 21
  • FIGURE 4 TOP-DOWN APPROACH 22
  • FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
  • FIGURE 6 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SHARE, BY TYPE, 2018 25
  • FIGURE 7 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SHARE, BY INDICATION, 2018 26
  • FIGURE 8 GEOGRAPHIC SNAPSHOT: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, 2018 27
  • FIGURE 9 GROWING PREVALENCE OF CHRONIC DISEASES IS LIKELY TO DRIVE THE MARKET FOR ELECTRONIC DRUG DELIVERY SYSTEMS 28
  • FIGURE 10 ELECTRONIC WEARABLE INFUSION PUMPS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET IN 2018 29
  • FIGURE 11 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 30
  • FIGURE 12 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 31
  • FIGURE 13 ELECTRONIC WEARABLE INFUSION PUMPS TO DOMINATE THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET IN THE FORECAST PERIOD 37
  • FIGURE 14 DIABETES INDICATIONS TO REGISTER THE HIGHEST CAGR OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET DURING THE FORECAST PERIOD 49
  • FIGURE 15 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2019 VS. 2024 62
  • FIGURE 16 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 65
  • FIGURE 17 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 70
  • FIGURE 18 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 77
  • FIGURE 19 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 84
  • FIGURE 20 MARKET SHARE ANALYSIS, BY KEY PLAYER (2018) 88
  • FIGURE 21 COMPETITIVE LEADERSHIP MAPPING: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 92
  • FIGURE 22 MERCK GROUP: COMPANY SNAPSHOT 93
  • FIGURE 23 MEDTRONIC PLC: COMPANY SNAPSHOT 95
  • FIGURE 24 UNITED THERAPEUTICS CORPORATION: COMPANY SNAPSHOT 97
  • FIGURE 25 INSULET CORPORATION: COMPANY SNAPSHOT 99
  • FIGURE 26 BAYER AG: COMPANY SNAPSHOT 101
  • FIGURE 27 NOVO NORDISK: COMPANY SNAPSHOT 103
  • FIGURE 28 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT 106
  • FIGURE 29 F.HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 108
  • FIGURE 30 AMGEN, INC.: COMPANY SNAPSHOT 110
  • FIGURE 31 ASTRAZENECA PLC: COMPANY SNAPSHOT 112
目次
Product Code: MD 7394

"The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019-2024)."

The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market is mainly driven by the favorable reimbursement scenario in North America & Europe, the growing prevalence of target diseases such as diabetes & cardiovascular disease, and advancements in technologies and designs of electronic drug delivery systems. Additionally, emerging markets such as China and India are expected to offer potential growth opportunities to market players in the coming years.

By type, the electronic wearable infusion pumps segment is expected to account for the largest share of the electronic drug delivery systems market

Based on type, the electronic drug delivery systems market is segmented into electronic wearable infusion pumps, electronic autoinjectors, electronic injection pens, and electronic inhalers. The electronic wearable infusion pumps segment is expected to account for the largest market share of the electronic drug delivery systems market in 2019. This is mainly due to the high prevalence of diabetes and the increasing availability of commercial infusion pumps for diabetes treatment.

By indication, the diabetes segment is to dominate the electronic drug delivery systems market during the forecast period

The diabetes segment accounted for the largest share of the market in 2018. This is mainly due to the high availability of electronic drug delivery devices such as insulin pumps and injection pens by major market players in comparison to other therapeutic areas, rising adoption of mobile apps for diabetes management, and increasing penetration of digital platforms (such as smartphones, tablet PCs, and personal digital assistants). For instance, in June 2018, Insulet Corporation (US), received the FDA approval for its Omnipod DASH Insulin Management System for diabetes management. Similarly, in June 2018, Tandem Diabetes Care (US), received the CE mark for its t:slim X2 Insulin Pump for diabetes management.

"North America is expected to witness the highest growth during the forecast period."

North America is expected to account for the largest share of the global electronic drug delivery system market in 2019, followed by Europe. Additionally, the US is also expected to witness the highest CAGR during the forecast period. This can primarily be attributed to the high incidence and prevalence of chronic conditions such as diabetes, asthma, CVD, and multiple sclerosis in the US. For instance, according to the IDF, there were about 30.2 million people suffering from diabetes in the US in 2017, and this figure is estimated to reach 35.6 million by 2045. Similarly, in 2017, approximately 25.2 million people had asthma in the US (Source:CDC). Furthermore, According to the American Heart Association, in 2017, about 801,000 deaths in the US are due to CVD. Obesity is a major risk factor for CVD and diabetes in the US; around 36.5% of adults in the country are obese (Source: CDC).

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-21%, Tier 2-26%, and Tier 3-53%
  • By Designation: C-level-32%, Director-level-26%, and Others-42%
  • By Region: North America-35%, Europe-30%, Asia Pacific-15%, Latin America-10%, Middle East & Africa-10%

The prominent players in the electronic drug delivery systems market are: United Therapeutics Corporation (US), Insulet Corporation (US), Novo Nordisk (Denmark), Bayer AG (Germany), Medtronic plc (Ireland), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).

Research Coverage:

The report analyzes the electronic drug delivery system market and aims at estimating the market size and future growth potential of the electronic drug delivery systems market and the different segments such as diabetes, multiple sclerosis, cardiovascular disease, asthma & COPD, and other indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson's disease). The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the electronic drug delivery system market.
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launch in the electronic drug delivery system market.
  • Market Development: Comprehensive information on lucrative emerging regions.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global electronic drug delivery system market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the electronic drug delivery system market.

TABLE OF CONTENTS

1 INTRODUCTION 15

  • 1.1 OBJECTIVES OF THE STUDY 15
  • 1.2 MARKET DEFINITION 15
  • 1.3 MARKET SCOPE 16
    • 1.3.1 MARKETS COVERED 16
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 16
  • 1.4 CURRENCY 17
  • 1.5 LIMITATIONS 17
  • 1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18

  • 2.1 RESEARCH DATA 18
    • 2.1.1 SECONDARY RESEARCH 19
      • 2.1.1.1 Key data from secondary sources 19
    • 2.1.2 PRIMARY RESEARCH 20
      • 2.1.2.1 Key data from primary sources 20
      • 2.1.2.2 Breakdown of primaries 21
  • 2.2 MARKET SIZE ESTIMATION 21
  • 2.3 DATA TRIANGULATION APPROACH 23
  • 2.4 MARKET SHARE ANALYSIS 24
  • 2.5 ASSUMPTIONS FOR THE STUDY 24

3 EXECUTIVE SUMMARY 25

4 PREMIUM INSIGHTS 28

  • 4.1 ELECTRONIC DRUG DELIVERY SYSTEMS: MARKET OVERVIEW 28
  • 4.2 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2018 29
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 30

5 MARKET OVERVIEW 31

  • 5.1 INTRODUCTION 31
  • 5.2 MARKET DYNAMICS 31
    • 5.2.1 DRIVERS 32
      • 5.2.1.1 Growing prevalence of target diseases 32
      • 5.2.1.2 Favorable reimbursement scenario in major markets 32
      • 5.2.1.3 Advancements in technologies and designs 33
    • 5.2.2 RESTRAINTS 33
      • 5.2.2.1 Preference for alternative drug delivery modes and the possibility of errors 33
    • 5.2.3 OPPORTUNITIES 34
      • 5.2.3.1 Increasing demand for biologics and mAbs 34
      • 5.2.3.2 Growth opportunities in emerging markets 35
    • 5.2.4 CHALLENGES 35
      • 5.2.4.1 Unfavorable reimbursement structure in developing countries 35

6 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 36

  • 6.1 INTRODUCTION 37
    • 6.1.1 ELECTRONIC WEARABLE INFUSION PUMPS 38
      • 6.1.1.1 Electronic wearable infusion pumps dominate the electronic drug delivery systems market 38
    • 6.1.2 ELECTRONIC AUTOINJECTORS 42
      • 6.1.2.1 Electronic autoinjectors are likely to register negative growth during the forecast period due to the continuous influx of generic versions of conventional autoinjectors in the market 42
    • 6.1.3 ELECTRONIC INJECTION PENS 44
      • 6.1.3.1 Growing focus of pharmaceutical companies on developing electronic/connected injection pens will drive market growth 44
    • 6.1.4 ELECTRONIC INHALERS 47
      • 6.1.4.1 Electronic inhalers are developed to improve medication adherence in asthma & COPD management 47

7 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 48

  • 7.1 INTRODUCTION 49
  • 7.2 DIABETES 50
    • 7.2.1 DIABETES ACCOUNTED FOR THE LARGEST SEGMENT OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 50
  • 7.3 MULTIPLE SCLEROSIS 52
    • 7.3.1 LAUNCH OF GENERIC VERSIONS OF CONVENTIONAL INJECTABLES WILL STIFLE MARKET GROWTH 52
  • 7.4 CARDIOVASCULAR DISEASE 54
    • 7.4.1 DEVELOPMENT OF INNOVATIVE ELECTRONIC DRUG DELIVERY SYSTEMS FOR CVD TREATMENT WILL DRIVE MARKET GROWTH 54
  • 7.5 ASTHMA & COPD 57
    • 7.5.1 DEVELOPMENT OF SMART INHALERS AND DIGITAL SENSORS IS LIKELY TO IMPROVE MEDICATION ADHERENCE IN ASTHMA & COPD PATIENTS 57
  • 7.6 OTHER INDICATIONS 58

8 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION 61

  • 8.1 INTRODUCTION 62
  • 8.2 NORTH AMERICA 64
    • 8.2.1 US 66
      • 8.2.1.1 The US has a favorable reimbursement scenario for electronic drug delivery devices, which is a key factor driving the market for electronic drug delivery systems 66
    • 8.2.2 CANADA 68
      • 8.2.2.1 Growing presence of device manufacturers in the country is expected to propel market growth 68
  • 8.3 EUROPE 69
    • 8.3.1 GERMANY 72
      • 8.3.1.1 Germany is the largest market for electronic drug delivery systems in Europe 72
    • 8.3.2 UK 73
      • 8.3.2.1 High burden of target diseases to support market growth 73
    • 8.3.3 FRANCE 74
      • 8.3.3.1 High prevalence of diabetes in the country to propel market growth 74
    • 8.3.4 REST OF EUROPE 75
  • 8.4 ASIA PACIFIC 76
    • 8.4.1 JAPAN 79
      • 8.4.1.1 Large geriatric population and the high prevalence of CVD to support market growth 79
    • 8.4.2 CHINA 80
      • 8.4.2.1 Growing focus of major players on biologics development to drive market growth 80
    • 8.4.3 INDIA 81
      • 8.4.3.1 Lack of reimbursement and guidelines on electronic drug delivery systems could limit market growth 81
    • 8.4.4 ROAPAC 82
  • 8.5 REST OF THE WORLD 83
    • 8.5.1 LATIN AMERICA 85
      • 8.5.1.1 High incidence of chronic diseases to drive the demand for electronic drug delivery systems 85
    • 8.5.2 MIDDLE EAST & AFRICA 86
      • 8.5.2.1 Favorable reforms in South Africa to support market growth 86

9 COMPETITIVE LANDSCAPE 88

  • 9.1 OVERVIEW 88
  • 9.2 MARKET SHARE ANALYSIS 88
  • 9.3 KEY PLAYER ANALYSIS 88
    • 9.3.1 MERCK GROUP 88
    • 9.3.2 MEDTRONIC PLC 89
  • 9.4 COMPETITIVE SCENARIO 89
    • 9.4.1 PRODUCT LAUNCHES 89
    • 9.4.2 EXPANSIONS 89
    • 9.4.3 AGREEMENTS & COLLABORATIONS 90
  • 9.5 COMPETITIVE LEADERSHIP MAPPING (2018) 91
    • 9.5.1 VISIONARY LEADERS 91
    • 9.5.2 INNOVATORS 91
    • 9.5.3 DYNAMIC DIFFERENTIATORS 91
    • 9.5.4 EMERGING COMPANIES 91

10 COMPANY PROFILES 93

(Business overview, Products offered, Recent Developments)*

  • 10.1 MERCK GROUP 93
  • 10.2 MEDTRONIC PLC 95
  • 10.3 UNITED THERAPEUTICS CORPORATION 97
  • 10.4 INSULET CORPORATION 99
  • 10.5 BAYER AG 101
  • 10.6 NOVO NORDISK 103
  • 10.7 COMPANION MEDICAL 105
  • 10.8 TANDEM DIABETES CARE, INC. 106
  • 10.9 F.HOFFMANN-LA ROCHE, LTD. 108
  • 10.10 AMGEN, INC. 110
  • 10.11 ASTRAZENECA PLC 112
  • 10.12 FINDAIR SP. Z O. O. 114
  • 10.13 VICENTRA B.V. 115
  • 10.14 CANE SPA 116
  • 10.15 DEBIOTECH S.A. 117

Details on Business overview, Products offered, Recent Developments might not be captured in case of unlisted companies.

11 APPENDIX 118

  • 11.1 DISCUSSION GUIDE 118
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 121
  • 11.3 RELATED REPORTS 123
  • 11.4 AUTHOR DETAILS 124
Back to Top